Is a complete AGL research report available?

No complete published report is available for agilon health, inc. (AGL) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

agilon health, inc. (AGL)

NYSE: AGL · USD

$92.7

-6.48 (-6.5%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first AGL analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	1.5B
Revenue (ttm)	5.8B
Net income (ttm)	-354.5M
EPS (ttm)	-$21.4
Shares out	16.7M
Volume	336,110
Beta	3.00
Price target	$71.6	-22.8%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 5.8B
Net income (ttm): -354.5M
EPS (ttm): -$21.4
Market cap: 1.5B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All AGL indicators

Market & fundamental data

Available fields

215

Groups with data

Currency

USD

Showing 215 of 215 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001831097
Company name	agilon health, inc.
Country	United States
Country code	US
Cusip	00857U206
Employees	856
Employees Change	-220%
Employees Change Percent	-20.45
Enterprise value	$1.3B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
Industry	Medical Care Facilities
Industry PE	16.55
Industry PE Fwd	15.65
IPO Date	2021-04-15
Isin	US00857U2069
Last refreshed	2026-07-30
Market cap	$1.5B
Market cap category	Small-Cap
Price	$92.66
Price currency	USD
Rev Per Employee	6,799,362.15x
Sector	Healthcare
Sector PE	45.63
Sector PE Fwd	24.38
Sic	8090
Symbol	AGL
Website	https://www.agilonhealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-22.93%
EV Sales Forward	0.23x
EV/Sales	0.23x
FCF yield	-4.05%
P/B ratio	8.48x
P/S ratio	0.27x
PS Forward	0.27x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-7.51%
EBITDA Margin	-7.02%
Gross margin	-2.5%
Gross Profit	$-145.7M
Gross Profit Growth Q	28.18%
Net Income	$-354.5M
Net Income Growth Q	303.86%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-6.4%
Profit Margin	-6.09%
Profit Per Employee	$-414,186
Profitable Quarters	$1
ROA	-14.16
Roa5y	-12.53
ROCE	-187.9
ROE	-109.6
Roe5y	-61.32
ROIC	-64.29

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	86.33%
Cagr3y	-41.86%
Cagr5y	-37.21%
EPS Growth Q	301
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	-2.82x
Revenue Growth Q	-7.33x
Revenue Growth Years	0x
Revenue Growth3 Y	27.79x
Revenue Growth5 Y	34.14x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$3.39
Assets	$1.5B
Cash	$231.4M
Current Assets	$1.3B
Current Liabilities	$1.3B
Debt	$33.4M
Debt Equity	$0.18
Equity	$181.4M
Interest Coverage	-63.01
Liabilities	$1.3B
Long Term Assets	$183.8M
Long Term Liabilities	$51.2M
Net Cash	$198M
Net Cash By Market Cap	$12.81
Net Cash Growth	-39.09%
Net Debt Equity	$-1.09
Tangible Book Value	$119M
Tangible Book Value Per Share	$7.17
WACC	20.67

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.04
Net Working Capital	$-167.8M
Quick ratio	0.92
Working Capital	$48.8M
Working Capital Turnover	$35.83

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.61%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	86.25%
200-day SMA	41.75
3Y total return	-80.36%
50-day SMA	104.8
50-day SMA vs 200-day SMA	50over200
5Y total return	-90.24%
All Time High	1,120.8
All Time High Change	-91.73%
All Time High Date	2021-06-18
All Time Low	7.48
All Time Low Change	1,138.77%
All Time Low Date	2026-03-31
ATR	10.49
Beta	3
Beta1y	6.1
Beta2y	2.5
Ch YTD	438.2
High	100.3
High52	133
High52 Date	2026-07-17
High52ch	-30.35%
Low	91.1
Low52	7.48
Low52 Date	2026-03-31
Low52ch	1,138.77%
Ma50ch	-11.59%
Price vs 200-day SMA	121.92%
RSI	37.63
RSI Monthly	47.55
RSI Weekly	61.27
Sharpe ratio	1.08x
Sortino ratio	2.16
Total Return	-0.61%
Tr YTD	438.2
Tr1m	-22.3%
Tr1w	-22.71%
Tr3m	232.12%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	17
Analyst Count Top	4
Analyst Price Target Top	$51
Analyst Ratings	Hold
Analyst Ratings Top	Buy
Earnings EPS Estimate	$0.14
Earnings Revenue Estimate	1,449,604,248x
Earnings Revenue Estimate Growth	3.91x
Operating Income	$-389.4M
Operating margin	-6.69
Price target	$71.57
Price Target Change	$-22.76
Price Target Change Top	$-44.96

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	9,802,782%
Float Percent	58.76%
Net Borrowing	-3,500,000
Shares Insiders	2.27%
Shares Institutions	54.42%
Shares Out	16,683,786
Shares Qo Q	0.47%
Shares Yo Y	0.61%
Short Float	8.77%
Short Ratio	2.61
Short Shares	5.15

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-101.2M
Adjusted OCF	-88,702,000
Average Volume	315,667.65x
Bv Per Share	10.93
CAPEX	$-12.5M
Ch1m	-22.3
Ch1w	-22.71
Ch1y	86.25
Ch3m	232.1
Ch3y	-80.36
Ch5y	-90.24
Ch6m	351.4
Change	-6.54%
Change From Open	-5.44
Close	99.14
Days Gap	-1.16
Depreciation Amortization	14,805,000
Dollar Volume	31,143,952.6
Earnings Date	2026-08-05
Earnings Time	amc
EBIT	$-437.1M
EBITDA	$-408.6M
EPS	$-21.38
F Score	2
FCF	$-62.5M
FCF EV Yield	-4.64x
FCF Per Share	$-3.75
Financing CF	-7,980,000
Fiscal Year End	December
Founded	2,016
Income Tax	$1.1M
Investing CF	130,971,000
Ipr	302.9
Iprfo	-86.88
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Date	2026-03-31
Last Split Type	Reverse
Last10k Filing Date	2026-02-25
Ma150	49.48
Ma150ch	87.28%
Ma20	112.5
Ma20ch	-17.64%
Net CF	72,943,000
Next Earnings Date	2026-08-05
Open	97.99
Optionable	Yes
Position In Range	16.94
Ppne	30,128,000
Price Date	2026-07-29
Ptbv Ratio	12.99
Relative Volume	1.06x
Revenue	5,820,254,000x
SBC By Revenue	0.66x
Share Based Comp	38,654,000
Tax By Revenue	0.02x
Tr6m	351.39%
Us State	Ohio
Volume	336,110
Z Score	1.55

agilon health, inc. (AGL)

Coverage state: Market snapshot only — no published research

Generate the first AGL analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · AGL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AGL indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on AGL

Frequently asked questions